2-(Benzofuran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

Boc-Phg-OH, >98%, 100g

GlcNAc beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP>97.0%(HPLC)2mg

(1S,2S)-N~1~,N~2~-Dibenzylcyclohexane-1,2-diamine Dihydrochloride>95.0%(HPLC)(T)5g

2-mercapto-3,6-dimethyl-6,7-dihydrothieno[3,2-d]pyrimidin-4(3H)-one, 95.0%, 500mg

5-(2-Methoxyethoxy)pyrazine-2-carboxylic acid, 1g

Methyl 4-fluoro-2-hydroxy-3-nitrobenzoate, 97%, 250mg

2-(2-Methoxyethoxy)acetonitrile, 95%, 100mg

4-Ethynyl-2-methylpyridine, 98%, 1g

3-(3-CHLOROPROPOXY)PROPAN-1-OL, 95%, 250mg

2-((2-((tert-Butoxycarbonyl)amino)ethyl)amino)acetic acid, 95+%, 5g

Methyl 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 10g

(1S,2S,4R)-4-(4-(N-((S)-2,3-dihydro-1H-inden-1-yl)benzamido)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-(hydroxymethyl)cyclopentyl benzoate, 98%, 50mg